Shitov Daniil A, Krutin Danil V, Tupikina Elena Yu
Institute of Chemistry, St. Petersburg State University, St. Petersburg, Russia.
J Comput Chem. 2024 May 15;45(13):1046-1060. doi: 10.1002/jcc.27309. Epub 2024 Jan 12.
Imidazole is a five-membered heterocycle that is part of a number of biologically important molecules such as the amino acid histidine and the hormone histamine. Imidazole has a unique ability to participate in a variety of non-covalent interactions involving the NH group, the pyridine-like nitrogen atom or the π-system. For many biologically active compounds containing the imidazole moiety, its participation in formation of hydrogen bond NH⋯O/N and following proton transfer is the key step of mechanism of their action. In this work a systematic study of the mutual influence of various paired combinations of non-covalent interactions (e.g., hydrogen bonds and π-interactions) involving the imidazole moiety was performed by means of quantum chemistry (PW6B95-GD3/def2-QZVPD) for a series of model systems constructed based on analysis of available x-ray data. It is shown that for considered complexes formation of additional non-covalent interactions can only enhance the proton-donating ability of imidazole. At the same time, its proton-accepting ability can be both enhanced and weakened, depending on what additional interactions are added to a given system. The mutual influence of non-covalent interactions involving imidazole can be classified as weak geometric and strong energetic cooperativity-a small change in the length of non-covalent interaction formed by imidazole can strongly influence its strength. The latter can be used to develop methods for controlling the rate and selectivity of chemical reactions involving the imidazole fragment in larger systems. It is shown that the strong mutual influence of non-covalent interactions involving imidazole is due to the unique ability of the imidazole ring to effectively redistribute electron density in non-covalently bound systems with its participation.
咪唑是一种五元杂环,是许多具有重要生物学意义的分子的组成部分,如氨基酸组氨酸和激素组胺。咪唑具有独特的能力,能够参与多种涉及NH基团、吡啶样氮原子或π体系的非共价相互作用。对于许多含有咪唑部分的生物活性化合物来说,其参与形成氢键NH⋯O/N以及随后的质子转移是其作用机制的关键步骤。在这项工作中,通过量子化学方法(PW6B95-GD3/def2-QZVPD),对基于现有X射线数据分析构建的一系列模型体系,系统研究了涉及咪唑部分的各种非共价相互作用(如氢键和π相互作用)的配对组合之间的相互影响。结果表明,对于所考虑的配合物,额外非共价相互作用的形成只会增强咪唑的质子供体能力。同时,其质子受体能力可能增强也可能减弱,这取决于给特定体系添加了哪些额外的相互作用。涉及咪唑的非共价相互作用的相互影响可分为弱几何协同性和强能量协同性——咪唑形成的非共价相互作用长度的微小变化会强烈影响其强度。后者可用于开发控制更大体系中涉及咪唑片段的化学反应速率和选择性的方法。结果表明,涉及咪唑的非共价相互作用的强烈相互影响是由于咪唑环在其参与的非共价结合体系中有效重新分布电子密度的独特能力。